Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Gallo

Showing results (1-10 of 123) with videos related to

Pageof 13
Sort By:
Clinical Pharmacology and Therapeutics|January 24, 2013
Physiologically based pharmacokinetic models of tyrosine kinase inhibitors: a systems pharmacological approach to drug dispositionJ M Gallo
Brain Research Bulletin|November 24, 2001
Kennedy's disease: a triplet repeat disorder or a motor neuron disease?J M Gallo
Journal of Neurovirology|February 25, 1998
The ins and outs of antiviral drug transport in the brainJ M Gallo
Clinical Pharmacokinetics|May 1, 1995
Zalcitabine. Clinical pharmacokinetics and efficacyD Devineni, J M Gallo
Journal of Chromatography|July 24, 1992
High-performance liquid chromatographic determination of the calcium channel blocker nimodipine in monkey plasmaM Qian, J M Gallo
European Journal of Cell Biology|March 1, 1985
Homologies between paraflagellar rod proteins from trypanosomes and euglenoids revealed by a monoclonal antibodyJ M Gallo, J Schrével
Apoptosis : an International Journal on Programmed Cell Death|December 4, 2003
Delivery of cytotoxic drugs from carrier cells to tumour cells by apoptosisJ Ma, J M Gallo
Advanced Drug Delivery Reviews|December 8, 2000
Application of microdialysis to characterize drug disposition in tumorsJ Chu, J M Gallo
Cancer Research|July 15, 1997
A.S. Lübbe et al., Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res., 56: 4694-4701, 1996; and Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res., 56: 4686-4693, 1996J M Gallo, U Hafeli
Biology of the Cell|January 1, 1988
Tubulin expression in trypanosomesJ M Gallo, E Precigout
Pageof 13

Showing results (1-10 of 123) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|January 24, 2013
Physiologically based pharmacokinetic models of tyrosine kinase inhibitors: a systems pharmacological approach to drug dispositionJ M Gallo
Brain Research Bulletin|November 24, 2001
Kennedy's disease: a triplet repeat disorder or a motor neuron disease?J M Gallo
Journal of Neurovirology|February 25, 1998
The ins and outs of antiviral drug transport in the brainJ M Gallo
Clinical Pharmacokinetics|May 1, 1995
Zalcitabine. Clinical pharmacokinetics and efficacyD Devineni, J M Gallo
Journal of Chromatography|July 24, 1992
High-performance liquid chromatographic determination of the calcium channel blocker nimodipine in monkey plasmaM Qian, J M Gallo
European Journal of Cell Biology|March 1, 1985
Homologies between paraflagellar rod proteins from trypanosomes and euglenoids revealed by a monoclonal antibodyJ M Gallo, J Schrével
Apoptosis : an International Journal on Programmed Cell Death|December 4, 2003
Delivery of cytotoxic drugs from carrier cells to tumour cells by apoptosisJ Ma, J M Gallo
Advanced Drug Delivery Reviews|December 8, 2000
Application of microdialysis to characterize drug disposition in tumorsJ Chu, J M Gallo
Cancer Research|July 15, 1997
A.S. Lübbe et al., Preclinical experiences with magnetic drug targeting: tolerance and efficacy. Cancer Res., 56: 4694-4701, 1996; and Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. Cancer Res., 56: 4686-4693, 1996J M Gallo, U Hafeli
Biology of the Cell|January 1, 1988
Tubulin expression in trypanosomesJ M Gallo, E Precigout
Pageof 13